
Enable job alerts via email!
A leading university in Singapore is seeking a motivated Clinical Trial Project Manager to coordinate the ACORN-HAI study focusing on antimicrobial resistance. The role involves managing international project operations, ensuring compliance with research regulations, and supporting the development of clinical research capabilities. Ideal candidates should have 3–5 years of relevant experience and a degree in Life Sciences or related fields.
Interested applicants are invited to apply directly at the NUS Career Portal. Your application will be processed only if you apply via the NUS Career Portal. We regret that only shortlisted candidates will be notified.
The ADVANcing Clinical Evidence in Infectious Diseases Network (ADVANCE-ID) is seeking a highly motivated and experienced Clinical Trial Project Manager to oversee the coordination and implementation of the ACORN-HAI study—a multi‑centre, international, patient‑centred surveillance project targeting healthcare‑associated infections due to antimicrobial resistance (AMR).
ADVANCE ID is jointly funded by the Wellcome Trust and Singapore institutions including the Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine, National University of Singapore. The vision of the Network is to improve public health by developing the clinical evidence base for the prevention and treatment of drug‑resistant infections. Its mission is to build and sustain a strategic clinical research network focussed on most efficiently delivering locally relevant interventions for drug‑resistant infections.
The Network aims to improve and strengthen clinical research capabilities in the region by acting as a platform to develop good principles and practices. It will stabilise capacity and capabilities to mitigate inefficiencies in trial start‑up phase and loss of skillset following study closure, as in typical trial setup. The Network will continuously develop its capabilities, quality and efficiency by learning from and collaborating with other clinical trial networks.
In the long term, the Network aims to support broader infectious disease studies by expanding geographically beyond its original starting point in South East Asia and collaborating with other networks around the world. It will function as an active network that involves patients in platform trials, allowing for rapid clinical research response in the event of an emerging infectious disease or pandemic threat.